Position in NTRA
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,792,406
+$923,300 QoQ
Shares Held
10,287
+10.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#326
of 844 holders
Holding Since
Mar 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ABN AMRO INVESTMENT SOLUTIONS holds $159,360,178 across 12 Diagnostics & Research names. NTRA ranks #5 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
126,330 | $63,336,808 | |
| 2 | DHR |
Danaher Corp /De/
|
297,041 | $56,580,369 | |
| 3 | DGX |
Quest Diagnostics Inc
|
98,878 | $20,957,191 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
20,692 | $3,998,108 | |
| 5 | NTRA |
Natera, Inc.
This page
|
10,287 | $2,792,406 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
4,867 | $2,562,183 | |
| 7 | A |
Agilent Technologies, Inc.
|
17,091 | $2,270,197 | |
| 8 | WAT |
Waters Corp /De/
|
5,406 | $2,027,466 |
All Filings in NTRA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,792,406 | 10,287 | Shares | Other | 2026-07-23 | |
| 2026-03-31 | $1,869,106 | 9,346 | Shares | Other | 2026-05-12 | |
| 2025-12-31 | $1,480,607 | 6,463 | Shares | Other | 2026-02-06 | |
| 2025-09-30 | $354,134 | 2,200 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $387,379 | 2,293 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $333,444 | 2,358 | Shares | Defined | 2025-08-27 | |
| 2023-06-30 | $565,088 | 11,613 | Shares | Defined | 2025-09-05 | |
| 2023-03-31 | $734,807 | 13,235 | Shares | Defined | 2025-09-05 | |
| No filing history on record for this holder in this stock. | ||||||